| Net Cash Provided by (Used in) Operating Activities |
$-3,000,000 |
USD |
-101.19% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$40,000,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$-50,000,000 |
USD |
43% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
324,000,000 |
shares |
0.12% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-8,000,000 |
USD |
-117.78% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$296,000,000 |
USD |
-20% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$60,000,000 |
USD |
40% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$51,000,000 |
USD |
-20.31% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$576,000,000 |
USD |
0.88% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$1,444,000,000 |
USD |
4.1% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$147,000,000 |
USD |
-52.43% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$1,838,000,000 |
USD |
2.7% |
Q4 2024 |
FY 2024 |
| Property, Plant and Equipment, Gross |
$2,705,000,000 |
USD |
5.8% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$238,000,000 |
USD |
-3.64% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.06 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$394,000,000 |
USD |
-2.23% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$38,000,000 |
USD |
-28.3% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$28,000,000 |
USD |
250% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$411,000,000 |
USD |
7% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$525,000,000 |
USD |
3.6% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$8,000,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$-260,000,000 |
USD |
-46.89% |
Q3 2024 |
Q3 2024 |